reference/26215461

Predicate	Object
contentType	Journal Article
endingPage	77
issn	1177-5475
issueIdentifier	4
pageRange	763-77
publicationName	Biologics : targets & therapy
startingPage	763
bibliographicCitation	Cassinotti A, Ardizzone S, Porro GB. Adalimumab for the treatment of Crohn's disease. Biologics. 2008 Dec;2(4):763–77. PMID: 19707457; PMCID: PMC2727899.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd9a811f61636bacecdc31b8aa2d836d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65629be3ea914631d14b9a29ceeac144 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5d668356178b7fd65d786af0c2dc481
date	200809
identifier	https://pubmed.ncbi.nlm.nih.gov/19707457 https://pubmed.ncbi.nlm.nih.gov/PMC2727899 https://doi.org/10.2147/btt.s3292
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36005 https://portal.issn.org/resource/ISSN/1177-5475
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Adalimumab for the treatment of Crohn’s disease
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7749 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9679 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7089 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7365 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127972406

Total number of triples: 29.